SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001161697-22-000096
Filing Date
2022-02-14
Accepted
2022-02-14 17:23:48
Documents
41
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q QUARTERLY REPORT FOR 12-31-2021 form_10-q.htm   iXBRL 10-Q 366814
2 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CEO ex_31-1.htm EX-31 10220
3 RULE 13(A)-14(A)/15(D)-14(A) CERTIFICATION OF CFO ex_31-2.htm EX-31 10211
4 SECTION 1350 CERTIFICATION OF CEO ex_32-1.htm EX-32 4985
5 SECTION 1350 CERTIFICATION OF CFO ex_32-2.htm EX-32 4976
  Complete submission text file 0001161697-22-000096.txt   2259534

Data Files

Seq Description Document Type Size
6 INLINE XBRL SCHEMA FILE gstc-20211231.xsd EX-101.SCH 22167
7 INLINE XBRL CALCULATION FILE gstc-20211231_cal.xml EX-101.CAL 25039
8 INLINE XBRL DEFINITION FILE gstc-20211231_def.xml EX-101.DEF 88556
9 INLINE XBRL LABEL FILE gstc-20211231_lab.xml EX-101.LAB 194140
10 INLINE XBRL PRESENTATION FILE gstc-20211231_pre.xml EX-101.PRE 149514
35 EXTRACTED XBRL INSTANCE DOCUMENT form_10-q_htm.xml XML 212335
Mailing Address 719 JADWIN AVENUE RICHLAND WA 99352
Business Address 719 JADWIN AVENUE RICHLAND WA 99352 206-451-1970
GlobeStar Therapeutics Corp (Filer) CIK: 0001502152 (see all company filings)

IRS No.: 273480481 | State of Incorp.: WY | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-55072 | Film No.: 22635054
SIC: 2834 Pharmaceutical Preparations